^
Association details:
Evidence:
Evidence Level:
Sensitive: D – Preclinical
Title:

FBXL20 promotes breast cancer malignancy by inhibiting apoptosis through degradation of PUMA and BAX

Published date:
09/26/2021
Excerpt:
...RASSF7 amplifcation and NF2 or LATS1/2 mutations were present in 50% of tumours and were accompanied by micromolar responses to the YAP1 inhibitor Verteporfn.
DOI:
https://doi.org/10.1016/j.jbc.2021.101253